Tue Jan 17, 2023 – 4:58 pm EST
(LifeSiteNews) — A vaccine adviser to the U.S. Food and Drug Administration (FDA) recently suggested that the latest bivalent COVID-19 booster shots should be saved for older adults with previously existing health issues and are unnecessary for healthy young people.
Dr. Paul Offit, who is also a pediatrics professor at the Children’s Hospital of Philadelphia, wrote an article presenting his argument that was published January 11 in the New England Journal of Medicine.
“Booster dosing is probably best reserved for the people most likely to need protection against severe disease — specifically, older adults, people with multiple coexisting conditions that put them at high risk for serious illness, and those who are immunocompromised,” Offit wrote. “In the meantime, I believe we should stop trying to prevent all symptomatic infections in healthy young people by boosting them with vaccines containing mRNA from strains that might disappear a few months later.”
Offit cited a study released in October that was “examining levels of neutralizing antibodies against BA.4 and BA.5 [subvariants of the omicron strain of COVID-19] after receipt of a monovalent or bivalent booster dose.” The researchers reportedly found “no
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors